Market Overview

UBS Data Shows Expedia, Priceline Doing Well...But Don't Sleep On TripAdvisor

Share:
UBS Data Shows Expedia, Priceline Doing Well...But Don't Sleep On TripAdvisor
Related EXPE
Your Easy Guide To Credit Suisse's New Top Stocks List
Affirm: The San Francisco Startup Using Fintech To Simplify Lending
Related PCLN
Trivago's Tribulations Not Likely Negative For Priceline, Expedia
Gadfly's Tan: TripAdvisor Is Finally 'Laying The Groundwork' To Be Acquired

UBS’ Eric J. Sheridan reiterated Buy ratings for Expedia Inc (NASDAQ: EXPE) and Priceline Group Inc (NASDAQ: PCLN), while saying that he was “incrementally more positive” on Neutral-rated Tripadvisor Inc (NASDAQ: TRIP). The price targets for Expedia and Priceline are at $145, $1,525, respectively. The price target for TripAdvisor has been raised from $68 to $69.

Commenting on the Instant Booking [IB] debate, Sheridan said that investors are concerned about moves to address leakage, or lost traffic conversion), in terms of travel research and conversion. TripAdvisor’s IB continues to be on the minds of all online travel investors, who consider this data for its impact on the company as well as the broader industry.

“While the transition continues to cause rev headwinds & deleverage in the medium-term, we see increased signs of TRIP’s monetization opportunity from “plugging the leak” – with two illustrative frameworks suggesting potential for ~10% upside to 2017 Street Click-based ad revs – conservatively showing overall hotel shopper conversion before 3%, which appears achievable to us,” Sheridan wrote.

Related Link: Piper Jaffray Upgrades Expedia To Overweight, Raises Target To $140

The analyst added that TripAdvisor is likely to benefit from higher repeat/return visits and engagement, both of which are concepts that the Street seemed to be underappreciating.

Incrementally Positive

Mentioning that he was “incrementally more positive” on TripAdvisor, Sheridan said that its risk-reward had improved. Although there are medium-term headwinds to the 1H16 estimates, there is a “growing chance” of the company beating Street expectations in 2H16 and 2017, backed by increased IB supply, better repeat/return behavior, and improved conversion.

Latest Ratings for EXPE

DateFirmActionFromTo
Aug 2017JefferiesUpgradesHoldBuy
Aug 2017SunTrust Robinson HumphreyInitiates Coverage OnBuy
Jul 2017ArgusInitiates Coverage OnBuy

View More Analyst Ratings for EXPE
View the Latest Analyst Ratings

Posted-In: Analyst Color Long Ideas Price Target Reiteration Travel Analyst Ratings Trading Ideas General Best of Benzinga

 

Related Articles (EXPE + PCLN)

View Comments and Join the Discussion!
Loading...
Loading...